Evidence map›Paper›PMID 42211291›Full record

ArticleCureus2026

Angiocentric Variant of Primary Cutaneous CD30-Positive Anaplastic Large Cell Lymphoma: A Case Report and Literature Review.

Mariana Herrera Ocampo, Guillermo Roa Alvarez, Mario Shuchleib Cukiert, Marcela Hernández Vera, Laura S Parra Jaramillo, Maria E Vega Memije

Abstract readCase Reports
In one paragraph

Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Mariana Herrera OcampoDepartment of Dermatology, Hospital General "Dr. Manuel Gea Gonzalez", Mexico City, MEX.
Guillermo Roa AlvarezSchool of Medicine and Health Sciences, Tecnológico de Monterrey, Mexico City, MEX.
Mario Shuchleib CukiertDepartment of Dermatology, Hospital General "Dr. Manuel Gea Gonzalez", Mexico City, MEX.
Marcela Hernández VeraDepartment of Dermatology, Hospital General "Dr. Manuel Gea Gonzalez", Mexico City, MEX.
Laura S Parra JaramilloDepartment of Dermatopathology, Hospital General "Dr. Manuel Gea Gonzalez", Mexico City, MEX.
Maria E Vega MemijeDepartment of Dermatology, Hospital General "Dr. Manuel Gea Gonzalez", Mexico City, MEX.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Anaplastic large cell lymphoma (ALCL) is part of the spectrum of CD30-positive lymphoproliferative disorders within cutaneous T-cell lymphomas. These disorders account for approximately 25%-30% of all primary cutaneous lymphomas (PCLs). Primary cutaneous ALCL (pcALCL) is an uncommon entity with heterogeneous clinical and histopathologic features, often posing a diagnostic challenge. We report a 79-year-old man who presented with a three-month history of a non-healing ulcer on the right lower limb following minor trauma. The lesion measured 6.7 × 9.8 × 0.3 cm and showed irregular erythematoviolaceous borders with areas of eschar. Histopathologic evaluation revealed a dense infiltrate of large atypical mononuclear cells with pleomorphic nuclei, prominent nucleoli, and atypical mitoses, accompanied by angiocentric and angiodestructive features. Immunohistochemistry demonstrated CD30 positivity in more than 75% of atypical cells and negative anaplastic lymphoma kinase (ALK) expression, confirming pcALCL. The patient responded favorably to electron beam radiotherapy. This case underscores the importance of early biopsy in atypical or treatment-refractory ulcers and highlights the diagnostic relevance of recognizing rare variants such as the angiocentric subtype.

Indexed as

alk-negative lymphomaangiocentric variant skin lymphomacd30 expressioncd30-positive lymphoproliferative disorderschronic ulcercutaneous t-cell lymphomadermatopathology immunohistochemistryprimary cutaneous anaplastic large cell lymphoma

Identifiers

PMID42211291
PMCPMC13215661

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.